About this page
ALT — Altimmune
Why Altimmune (ALT) moved: the last session's move split into the market, its industry, its themes and the part unique to the company, with our latest explained moves and their sources, beside the live chart.
On Wednesday, November 18, 2026, Altimmune (ALT) fell 9.15% at the close. Where it came from: Market (SPY) -0.50%, Biotechnology -0.93%, Factors (6) +1.99%, Unique to ALT -9.71%. Most of ALT's decline was unique to the stock; factors cushioned it.
Altimmune (ALT) last reported earnings on Thursday, November 12, 2026, before the open (SEC 8-K); that session, ALT fell 16.58% at the close — why ALT moved on Nov 12, 2026. Its next report is estimated for about Thursday, February 11, 2027 (between February 10 and February 12), before the open, from its own rhythm across 9 reports; not yet announced. The earnings calendar.
Explained moves for ALT:
- Thursday, November 12, 2026: ALT fell 16.6% on the day it reported Q3 results, with a slightly wider loss than expected and no sales (sec.gov, Benzinga)
Each explained move has its own page: Thursday, November 12, 2026.
Only on this page: ALT's split updating every minute while the market is open, which of the 6 factors moved it and by how much, and the catalyst behind its explained move, with sources.
Explore daily moves on this page shows where ALT's moves came from, session by session — the market, its industry, its themes, its factors and its own part. The month and three-month views are free; six months, the year to date and the full year, with every day's breakdown and its full explanation, are part of TickerTiles Plus.
All stocks: Why stocks moved. The whole market: Market Overview.